Topics

Nonpersistence, Low Adherence to BP Meds Common in Under 65s

08:00 EDT 15 Aug 2019 | Drugs.com

THURSDAY, Aug. 15, 2019 -- Nonpersistence and low adherence are common among younger adults initiating antihypertensive medications and have not improved over time, according to a study published in the July issue of Hypertension. Gabriel S. Tajeu,...

Original Article: Nonpersistence, Low Adherence to BP Meds Common in Under 65s

NEXT ARTICLE

More From BioPortfolio on "Nonpersistence, Low Adherence to BP Meds Common in Under 65s"

Quick Search

Relevant Topic

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...